The C-reactive protein to albumin ratio predicts postoperative complications in oldest-old patients with colorectal cancer.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Mar 2020
Historique:
accepted: 11 12 2019
pubmed: 4 1 2020
medline: 20 11 2020
entrez: 4 1 2020
Statut: ppublish

Résumé

The C-reactive protein to albumin ratio (CAR) is a simple and useful score for predicting the outcomes of patients with various cancers. The aim of this study was to evaluate the CAR and short-term outcomes in oldest-old patients with colorectal cancer. A total of 126 patients aged 85 years and older with colorectal cancer who underwent resection for primary colon cancer from April 2015 to December 2018 were included. The preoperative cutoff value of the CAR for predicting postoperative complications was 0.19 on receiver operating characteristic curve analysis. Clinical characteristics and inflammation-based scores were compared between patients with a high CAR (CAR ≥ 0.19, n = 44) and a low CAR (CAR < 0.19, n = 82). A high preoperative CAR level (≥ 0.19) was significantly associated with stoma construction (p = 0.004), blood loss (p = 0.003), postoperative complications (p = 0.016), and systemic inflammation marker levels, including a low neutrophil to lymphocyte ratio (p = 0.006), a low platelet to lymphocyte ratio (p = 0.005), a low prognostic nutritional index (p < 0.001), and a high modified Glasgow prognostic score (p < 0.001). On univariate and multivariate analyses, only the CAR was an independent predictor of postoperative complications (HR 2.864, p = 0.029). A high CAR was significantly associated with postoperative complications for oldest-old patients with colorectal cancer.

Identifiants

pubmed: 31897648
doi: 10.1007/s00384-019-03491-z
pii: 10.1007/s00384-019-03491-z
doi:

Substances chimiques

Biomarkers 0
Serum Albumin 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-431

Références

Ann Surg. 2012 Jun;255(6):1060-8
pubmed: 22549749
J Am Geriatr Soc. 2005 Mar;53(3):424-9
pubmed: 15743284
Am J Clin Oncol. 2000 Jun;23(3):263-6
pubmed: 10857890
Transl Oncol. 2015 Aug;8(4):339-45
pubmed: 26310380
Int J Colorectal Dis. 2017 Nov;32(11):1625-1629
pubmed: 28932975
Ann Surg Oncol. 2016 Jun;23(6):1875-82
pubmed: 26786093
Med Oncol. 2012 Dec;29(4):2800-8
pubmed: 22460836
Rev Recent Clin Trials. 2015;10(2):135-41
pubmed: 25778832
J Am Geriatr Soc. 2013 Apr;61(4):495-501
pubmed: 23521576
Ann Surg Oncol. 2016 Mar;23(3):900-7
pubmed: 26530445
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Ann Surg. 2008 Aug;248(2):212-20
pubmed: 18650630
Anticancer Res. 2016 Mar;36(3):995-1001
pubmed: 26976989
Surg Oncol. 2018 Dec;27(4):730-736
pubmed: 30449500
World J Surg. 2016 Sep;40(9):2254-60
pubmed: 26956901
Colorectal Dis. 2012 Jul;14(7):e395-9
pubmed: 22288556
Med Oncol. 2014 Dec;31(12):305
pubmed: 25355641
Dis Colon Rectum. 2014 Aug;57(8):967-75
pubmed: 25003291
Biomed Res Int. 2018 Mar 11;2018:2176056
pubmed: 29713641
Dig Surg. 2015;32(1):32-8
pubmed: 25678189
Crit Rev Oncol Hematol. 2005 Sep;55(3):241-52
pubmed: 16084735
PLoS One. 2013;8(3):e59321
pubmed: 23555017
Surg Endosc. 1995 Oct;9(10):1101-5
pubmed: 8553212
Ann Surg Oncol. 2011 Jun;18(6):1533-9
pubmed: 21445672
Int J Surg. 2016 Nov;35:28-33
pubmed: 27616059
Dis Colon Rectum. 2015 Nov;58(11):1048-57
pubmed: 26445177
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
N Z Med J. 2003 Apr 17;116(1172):U402
pubmed: 12740622
Br J Cancer. 2009 Apr 21;100(8):1236-9
pubmed: 19319134
Ann Surg. 2018 Aug;268(2):318-324
pubmed: 28628565
Br J Surg. 1999 Jul;86(7):938-41
pubmed: 10417569
Ann Surg Oncol. 2016 Feb;23 Suppl 2:S257-65
pubmed: 25752891
Int J Colorectal Dis. 2016 Sep;31(9):1611-7
pubmed: 27357511
Ann Surg. 2014 Jul;260(1):23-30
pubmed: 24509190
Ann Surg Oncol. 2012 Aug;19(8):2428-34
pubmed: 22396000

Auteurs

Shintaro Hashimoto (S)

Department of Surgery, Saiseikai Nagasaki Hospital, 2-5-1 Katafuchi, Nagasaki, 850-0003, Japan.
Departments of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.

Tetsuro Tominaga (T)

Departments of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. tetsuro.tominaga@nagasaki-u.ac.jp.

Takashi Nonaka (T)

Departments of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.

Kiyoaki Hamada (K)

Department of Surgery, Sasebo City General Hospital, 9-3 Hirasemati, Sasebo, 857-8511, Japan.

Masato Araki (M)

Department of Surgery, Sasebo City General Hospital, 9-3 Hirasemati, Sasebo, 857-8511, Japan.

Hiroaki Takeshita (H)

Department of Surgery, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Ōmura, 856-8562, Japan.

Hidetoshi Fukuoka (H)

Department of Surgery, Isahaya General Hospital, 24-1 Eisyohigasi, Isahaya, 854-8501, Japan.

Hideo Wada (H)

Department of Surgery, Ureshino Medical Center, 4279-3 Ureshino, Saga, 843-0393, Japan.

Kazuo To (K)

Department of Surgery, Ureshino Medical Center, 4279-3 Ureshino, Saga, 843-0393, Japan.

Hideaki Komatsu (H)

Department of Surgery, Saiseikai Nagasaki Hospital, 2-5-1 Katafuchi, Nagasaki, 850-0003, Japan.

Kenji Tanaka (K)

Department of Surgery, Saiseikai Nagasaki Hospital, 2-5-1 Katafuchi, Nagasaki, 850-0003, Japan.

Terumitsu Sawai (T)

Departments of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.

Takeshi Nagayasu (T)

Departments of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH